These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 38553375
21. Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial. Rubin BR, Burton R, Navarra S, Antigua J, Londoño J, Pryhuber KG, Lund M, Chen E, Najarian DK, Petruschke RA, Ozturk ZE, Geba GP. Arthritis Rheum; 2004 Feb; 50(2):598-606. PubMed ID: 14872504 [Abstract] [Full Text] [Related]
24. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557 [Abstract] [Full Text] [Related]
25. Prednisolone Versus Colchicine for Acute Gout in Primary Care (COPAGO): protocol for a two-arm multicentre, pragmatic, prospective, randomized, double-blind, controlled clinical trial of prednisolone and colchicine for non-inferiority with a parallel group design. Truthmann J, Freyer Martins Pereira J, Richter A, Schuster F, Witte A, Böhm S, Greser A, Kamin P, Stracke S, Dörr M, Bülow R, Engeli S, Gágyor I, Hummers E, Chenot JF. Trials; 2023 Oct 05; 24(1):643. PubMed ID: 37798801 [Abstract] [Full Text] [Related]
26. Hongjin Xiaojie Capsule, a Chinese patent medicine, for treating moderate to severe cyclical breast pain: A single-blind randomized controlled trial. Zhang Q, Fan YY, Wu XQ, Huo YD, Wang CH, Liang SB, Wang T, Zhong R, Wang X, Lai BY, Pei XH, Liu JP. J Integr Med; 2024 Sep 05; 22(5):552-560. PubMed ID: 39232973 [Abstract] [Full Text] [Related]
33. Zhengqing fengtongning sustained-release tablets prevents gout flares in the process of ULT: A randomized, positive control, double-blind, double-simulation, multicenter trial. Jia E, Hu S, Geng H, Zhu H, Xie J, Xiao Y, Jiang Y, Xiao M, Zhang J. Medicine (Baltimore); 2022 May 06; 101(18):e29199. PubMed ID: 35550468 [Abstract] [Full Text] [Related]
34. A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis. Matsumoto AK, Melian A, Mandel DR, McIlwain HH, Borenstein D, Zhao PL, Lines CR, Gertz BJ, Curtis S, Etoricoxib Rheumatoid Arthritis Study Group. J Rheumatol; 2002 Aug 06; 29(8):1623-30. PubMed ID: 12180720 [Abstract] [Full Text] [Related]
38. The efficacy and safety of Chinese herbal medicine Shen-Qi Hua-Yu formula in patients with diabetic lower extremity artery disease: Study protocol of a multi-center, randomized, double-blind, placebo-controlled trial. Leng Y, Gao H, Fu X, Xie H, Hu Z, Zhu J, Liu X, Zhou X, Xie Z, Xie C. Medicine (Baltimore); 2020 Jan 06; 99(3):e18713. PubMed ID: 32011447 [Abstract] [Full Text] [Related]
39. Etoricoxib in acute pain associated with dental surgery: a randomized, double-blind, placebo- and active comparator-controlled dose-ranging study. Malmstrom K, Sapre A, Couglin H, Agrawal NG, Mazenko RS, Fricke JR. Clin Ther; 2004 May 06; 26(5):667-79. PubMed ID: 15220011 [Abstract] [Full Text] [Related]
40. Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial. Bickham K, Kivitz AJ, Mehta A, Frontera N, Shah S, Stryszak P, Popmihajlov Z, Peloso PM. BMC Musculoskelet Disord; 2016 Aug 08; 17():331. PubMed ID: 27502582 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]